Successful Treatment of Tuberculosis‐Associated Hypercalcemia With Denosumab in a Patient With Acute Kidney Injury
Author:
Affiliation:
1. Department of Internal Medicine, University of Mississippi Medical Center Jackson MS USA
2. Department of NephrologyUniversity of Mississippi Medical Center Jackson MS USA
Publisher
Wiley
Subject
Nephrology,Hematology
Link
https://onlinelibrary.wiley.com/doi/pdf/10.1111/1744-9987.12788
Reference4 articles.
1. Denosumab
2. FoodU AdministrationD.FDA Labeling Information‐Prolia (Denosumab). FDA Website.2010.
3. Denosumab in hypercalcemia of malignancy: A case series
4. Hypocalcemia and bone mineral density changes following denosumab treatment in end-stage renal disease patients: a meta-analysis of observational studies
Cited by 7 articles. 订阅此论文施引文献 订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献
1. Efficacy of denosumab in the treatment of hypercalcemic renal dysfunction in sarcoidosis: a case report;Osteoporosis International;2023-12-16
2. Consensus Statement der Österreichischen Gesellschaften für Rheumatologie und Rehabilitation, Pneumologie, Infektiologie, Dermatologie und Gastroenterologie zum Umgang mit latenter Tuberkulose bei Therapien mit biologischen oder „targeted synthetic“ DMARDs („disease modifying antirheumatic drugs“);Zeitschrift für Rheumatologie;2022-11-07
3. National consensus statement by the Austrian Societies for Rheumatology, Pulmonology, Infectiology, Dermatology and Gastroenterology regarding the management of latent tuberculosis and the associated utilization of biologic and targeted synthetic disease modifying antirheumatic drugs (DMARDs);Wiener klinische Wochenschrift;2022-08-29
4. Association Between Antiosteoporotic Drugs and Risk of Acute Kidney Injury: A Cross‐Sectional Study Using Disproportional Analysis and a Pharmacovigilance Database;The Journal of Clinical Pharmacology;2022-06-23
5. Refractory hypercalcemia in a patient with end stage renal disease;Indian Journal of Nephrology;2022
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3